Siemens Healthineers AG

SHL

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2025

    Employees

    73,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,939.70378.005.00%
CAC 406,896.91203.51-2.87%
DAX 4019,670.88609.38-3.00%
Dow JONES (US)40,608.4562.520.15%
FTSE 1007,705.87204.66-2.59%
HKSE20,264.49136.810.68%
NASDAQ17,124.97574.373.47%
Nikkei 22534,269.712,555.688.06%
NZX 50 Index12,232.46425.913.61%
S&P 5005,456.90474.139.52%
S&P/ASX 2007,742.40367.404.98%
SSE Composite Index3,186.810.000.00%

Market Movers